drugset / Trial / NCT00966368
Comparison of Two NN1250 Formulations in Healthy Volunteers
RandomizedCrossoverDouble-blindTreatment
Summary
This trial was conducted in North America. The aim of this clinical trial was to investigate if two formulations of NN1250 (insulin degludec) have the same level of drug exposure to the body.
Timeline
- Start
- 2009-08
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin degludec | Protein / enzyme biologic | 0.4 iu/kg | Subcutaneous |